Jump to navigation
The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
Our meeting has a standing location: 225 E. 16th Avenue, 1st. Floor Conference Room, Denver, Colorado
1:00 p.m. - 5:00 p.m.
The Board meets once quarterly in January, April, July, and October
October
July
April 7, 2015
January 6, 2015
October 7, 2014
July 8, 2014
April 8, 2014
January 7, 2014
The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.
